APHOBAZOLUM AND PYRAZIDOL IN A COMPLEX TREATMENT OF THE PATIENTS WITH CORONARY HEART DISEASE AND ANXIETY AND DEPRESSIVE DISORDERS

Abstract

The paper focuses on the co-morbidity of coronary heart disease (CHD) and anxiety and depressive disorders. The effects of psycho-emotional pathology on quality of life are discussed. The importance of complex treatment, including selective psychotropic therapy, is emphasised.

Keywords

• coronary heart disease
• anxiety and depressive disorders
• treatment
• aphobazolum
• pyrazidol